Clinical Study Results
Research Sponsor: MedImmune
Treatment Studied: MEDI3506
Study Title: A study to learn about the safety and tolerability
of MEDI3506 in healthy participants, in participants with
chronic obstructive pulmonary disease, and in healthy
Japanese participants
Thank you
Thank you to the participants who took part in the clinical study for the study
treatment MEDI3506. MedImmune sponsored this study and thinks it is important
to share the results of the study. An independent non-profit organization called
CISCRP helped prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
Who took part in this study?
There were 3 parts to this study. The researchers asked for the help of different
participants for each part.
• Part 1 included men and women who had mild allergies. These participants were
23 to 55 years old when they joined the study.
• Part 2 included men and women who had chronic obstructive pulmonary disease,
also called COPD. These participants were 55 to 71 years old when they joined the
study.
• Part 3 included healthy Japanese men. These participants were 25 to 48 years old
when they joined the study.
Overall, the study included a total of 88 participants in the United Kingdom.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1